BarclayHedge: Hedge Funds Add 2.11% In Sept.

Oct 15 2013 | 12:41pm ET

Hedge funds posted widespread gains in September but failed to match the broader markets, buoyed by a rally in stocks.

Seventeen of BarclayHedge's 18 industry indices gained ground last month. The overall Barclay Hedge Fund Index added 2.11% and is up 7.3% on the year.

"The Fed's decision to delay tapering surprised investors and drove equity prices higher through mid-month," BarclayHedge founder Sol Waksman said. "Fears over the possible failure of U.S. budget and debt-ceiling negotiations gained momentum and equity markets sold off in the second half of September, but equities remained profitable on the month as measured by a gain of 5% for the MSCI World Index."

The best-performing strategy in September—and on the year—is healthcare and biotechnology, up 4.26% on the month and 27.91% on the year. "The passage of the Affordable Care Act in the U.S., coupled with the expectation of greater demand for healthcare services due to increases in both population and life expectancy, have had a very positive impact on the sector."

Equity long-bias funds rose 3.65% in September (15.24% YTD), technology funds 3.35% (9.38% YTD), emerging markets funds 2.92%, Pacific Rim equities 2.62% (17.2% YTD) and European equities 2.03%.

Short-bias funds were the only losers on the month, dropping 3.55%. The strategy is down 19.84% on the year.

The Barclay Fund of Funds Index returned 1.33% in September (4.95% YTD).


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

As initial anxiety over Donald Trump’s victory gave way to market euphoria in the days following the election, there was a casualty. Gold prices.